[iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2017 Ended March 31, 2018 BEIJING, JUNE 21, 2018 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast growing private preventive health]
[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]
[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]
[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]
[Execution Version AMENDMENT NO. 4 TO RIGHTS AGREEMENT Amendment Rights Agreement Company Rights Agent AMENDMENT NO. 4 (this WHEREAS, the Board of Directors desires to amend the Rights Agreement as set forth herein; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has appr]
[Execution Version AMENDMENT NO. 4 TO RIGHTS AGREEMENT Amendment Rights Agreement Company Rights Agent AMENDMENT NO. 4 (this WHEREAS, the Board of Directors desires to amend the Rights Agreement as set forth herein; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has appr]
